Human Molecular Genetics, 2002, Vol. 11, No. 2 199-206
© 2002 Oxford University Press
Molecular classification of primary breast tumors possessing distinct prognostic properties
1Taisho Laboratory of Functional Genomics, Nara Institute of Science and Technology, 8916-5 Takayama, Ikoma, Nara, 630-0101, Japan and 2Department of Surgical Oncology, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan
The natural progression of breast cancer differs greatly between patients; the precise prediction of this disease course will improve the efficacy of therapeutics. Gene expression profiling may elucidate the undiscovered biological variations between seemingly similar cancers, leading to a new cancer classification system valuable in accurate diagnosis. The expression levels of 2412 genes, derived from 98 cancer samples, were precisely recorded by a high throughput RT–PCR technique, adapter-tagged competitive PCR. Subsequent cluster analysis revealed a molecular profile, correlating with estrogen receptor levels and the presence of lymph node metastases. We analyzed 301 cancer samples for the expression patterns of 21 genes critical in this categorization. The classification of the samples into three major groups was verified utilizing principal component analysis. This molecular classification system correlated significantly with early recurrence, independent of lymph node status. This malignant potential is associated with the expression levels of a group of genes, which comprise a set of candidates potentially useful in diagnostic prediction. These genes and the associated control mechanisms may also be effective therapeutic targets.
+ To whom correspondence should be addressed. Tel: +81 743 725583; Fax: +81 743 725589; Email: kkato@bs.aist-nara.ac.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Raulic, Y. Ramos-Valdes, and G. E DiMattia Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro J. Endocrinol., June 1, 2008; 197(3): 517 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C.-M. Chang, J. Hook, F. A. Lemckert, M. M. McDonald, M.-A. T. Nguyen, E. C. Hardeman, D. G. Little, P. W. Gunning, and R. R. Reddel The Murine Stanniocalcin 2 Gene Is a Negative Regulator of Postnatal Growth Endocrinology, May 1, 2008; 149(5): 2403 - 2410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Diallo-Danebrock, E. Ting, O. Gluz, A. Herr, S. Mohrmann, H. Geddert, A. Rody, K.-L. Schaefer, S. E. Baldus, A. Hartmann, et al. Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose-Dense Chemotherapy Clin. Cancer Res., January 15, 2007; 13(2): 488 - 497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K Gruvberger-Saal, H. E Cunliffe, K. M Carr, and I. A Hedenfalk Microarrays in breast cancer research and clinical practice - the future lies ahead Endocr. Relat. Cancer, December 1, 2006; 13(4): 1017 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Dolled-Filhart, L. Ryden, M. Cregger, K. Jirstrom, M. Harigopal, R. L. Camp, and D. L. Rimm Classification of breast cancer using genetic algorithms and tissue microarrays. Clin. Cancer Res., November 1, 2006; 12(21): 6459 - 6468. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Keeton and M. Brown Cell Cycle Progression Stimulated by Tamoxifen-Bound Estrogen Receptor-{alpha} and Promoter-Specific Effects in Breast Cancer Cells Deficient in N-CoR and SMRT Mol. Endocrinol., June 1, 2005; 19(6): 1543 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Iwao-Koizumi, R. Matoba, N. Ueno, S. J. Kim, A. Ando, Y. Miyoshi, E. Maeda, S. Noguchi, and K. Kato Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling J. Clin. Oncol., January 20, 2005; 23(3): 422 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kato, R. Yamashita, R. Matoba, M. Monden, S. Noguchi, T. Takagi, and K. Nakai Cancer gene expression database (CGED): a database for gene expression profiling with accompanying clinical information of human cancer tissues Nucleic Acids Res., January 1, 2005; 33(suppl_1): D533 - D536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kurokawa, R. Matoba, H. Nagano, M. Sakon, I. Takemasa, S. Nakamori, K. Dono, K. Umeshita, N. Ueno, S. Ishii, et al. Molecular Prediction of Response to 5-Fluorouracil and Interferon-{alpha} Combination Chemotherapy in Advanced Hepatocellular Carcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6029 - 6038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Makretsov, D. G. Huntsman, T. O. Nielsen, E. Yorida, M. Peacock, M. C. U. Cheang, S. E. Dunn, M. Hayes, M. van de Rijn, C. Bajdik, et al. Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6143 - 6151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Ding, J. Yan, J. Zhu, H. Zhong, Q. Lu, Z. Wang, C. Huang, and Q. Ye Ligand-independent activation of estrogen receptor {alpha} by XBP-1 Nucleic Acids Res., September 15, 2003; 31(18): 5266 - 5274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Buckhaults, Z. Zhang, Y.-C. Chen, T.-L. Wang, B. St. Croix, S. Saha, A. Bardelli, P. J. Morin, K. Polyak, R. H. Hruban, et al. Identifying Tumor Origin Using a Gene Expression-based Classification Map Cancer Res., July 15, 2003; 63(14): 4144 - 4149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Saito, R. Matoba, N. Ueno, K. Matsubara, and K. Kato Comparison of gene expression profiling during postnatal development of mouse dentate gyrus and cerebellum Physiol Genomics, February 28, 2002; 8(2): 131 - 137. [Abstract] [Full Text] [PDF]
|
|